Modest Alcohol Consumption Will Not Protect Against Obesity, T2DM Risk
An investigation explored dose-dependent effects of alcohol consumption of type 2 diabetes mellitus and obesity risk.
An investigation explored dose-dependent effects of alcohol consumption of type 2 diabetes mellitus and obesity risk.
Efficacy, safety, and tolerability of higher investigational doses of oral semaglutide vs the standard 14-mg dose were evaluated among patients with inadequately controlled type 2 diabetes.
Researchers performed a meta-analysis study to determine the effects of cinnamon on glycemic control in patients with T2D or PCOS.
Several associations, including the AHA, ACC, and NLA, have issued new guidelines for management of patients with chronic coronary disease.
A phase 3 clinical trial examined the efficacy of semaglutide 50 mg for treating overweight and obesity in adults without type 2 diabetes.
Investigators compared sodium-glucose cotransporter-2 inhibitors (SGLT2i) and dipeptidyl peptidase 4 inhibitors (DPP-4is) in a propensity-score matched group of patients with gout and type 2 diabetes.
Highlights from National Lipid Association Scientific Sessions 2023 include metabolic syndrome, diabetes, HEAT assessment tool, and lifestyle interventions.
Investigators examined changes in HbA1c levels and fasting plasma glucose, and adverse events in individuals with type 2 diabetes following danuglipron treatment.
In a large population-based cohort study, researchers evaluated whether the association of prediabetes with dementia is explained by the intervening onset of diabetes.
Brenzavvy is an oral sodium-glucose cotransporter 2 inhibitor.